SS26 COVID Campaign Guidance & Updates
|
There have been a number of queries raised with regard to the SS26 COVID campaign that is running from Monday 13 April to Tuesday 30 June 2026, in an effort to support you all we have provided centralised guidance, FAQs and updates below. This will continue to be updated throughout the campaign as and when new information is released. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OFF-SITE DELIVERY OF COVID-19 VACCINATIONSAs per paragraph 4.12 of the Community Pharmacy advanced service specification for COVID-19 and adult influenza vaccination programmes: 1 April 2026 to 31 March 2027 Pharmacy contractors are required to obtain consent from the commissioners if they wish to carry out vaccinations at a location other than the pharmacy premises e.g long-stay care home, patients home etc. The Seasonal COVID-19 and Influenza Vaccination Services are a nationally specified service, with responsibilities for oversight and assurance delegated to NHS England’s regional commissioning team. If
Community Pharmacy COVID-19 and Influenza 2026-27 off-site vaccination permission This can be completed using a computer or smart phone and should only take a few minutes. If you are unable to access MS forms for any reason, please instead contact the RVOC team on england.eoe-vacprg@nhs.net for support. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VACCINE GROUP DIRECTIVEThe Vaccine Group Direction (VGD) for the COVID-19 Spring 2026 vaccination programme has been published. This new legal mechanism will enable some elements of vaccination activity to be delegated. NHS Specialist Pharmacy Service have published guidance to support teams in Understanding VGDs.
NHS England has provided central organisational authorisation for this VGD. For providers using a VGD model for service delivery, vaccinating teams should read, understand and be locally authorised to use the document (completing the self-declaration and local manager countersignature in Section 7) prior to vaccinating.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IMMUNISATION-RELATED INCIDENT REPORTINGThere is now an electronic incident form for reporting any immunisation-related incidents to NHS England. How it Works:
Please see the NHSE website for the latest cold chain policy If you are unsure of what classes as an incident, please see: Vaccine incident guidance: Responding to errors in vaccine storage, handling and administration |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SPIKEVAX – SMALL PACKS AVAILABLENew smaller pack sizes of Spikevax (LP.8.1) are now available to order through the Supply Dashboard on FDP from Tuesday 31 March, with first deliveries to sites from 7 April onwards. Alongside the existing 50 dose (10 vial) pack, sites can now order a smaller 10 dose (2 vial) pack with a maximum cap of 30 doses (6 vials) for smaller pack size of Spikevax. This gives sites greater flexibility to order volumes that more closely match their planned vaccination activity, helping to reduce the risk of expiry waste.
Please note: orders of up to 30 doses (3 smaller packs) will be fulfilled using the 10 dose pack. Orders above this threshold will be fulfilled using the full 50 dose pack where smaller packs have been exhausted. Sites will be able to place orders for 10, 20, 30, 50 and multiples of 50 doses. Any orders above 30 doses will have to be in the multiple of 50 i.e. sites cannot order 80 or 120 doses of Spikevax LP.8.1. Spikevax Shelf Life and Clinic Availability Alignment Spikevax LP.8.1 has a maximum 30-day refrigerated shelf life once thawed. As some shelf life is used during distribution, vaccine received at your site will therefore have less than 30 days remaining. Sites should plan vaccination activity accordingly and avoid holding surplus stock. Given this, sites should order little and often, placing smaller, more frequent orders aligned to confirmed clinic activity rather than ordering in bulk. Increased logistical capacity is in place to support more frequent deliveries, so sites do not need to hold large amounts of stock to maintain continuity of supply. Smaller pack sizes (10, 20, and 30 doses) of Spikevax LP.8.1 are available through the FDP Supply Dashboard to help sites match order volumes more precisely to planned demand.
To minimise expiry risk, sites should order vaccine in line with confirmed clinic activity and use smaller pack sizes where available to match volumes more precisely to planned demand.
Where operational circumstances require delivery of vaccine with less than 7 days of shelf-life remaining, we expect to notify providers in advance.
Consumables Stocktake reminder |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UPDATE ON ALLOCATION DONATION PROCESSDue to a technical issue, the allocation donation function will not be available directly to providers in the FDP Supply Dashboard for the Spring 2026 programme. What this means for providers If you need to donate your allocation to another site, to support collaboration, or if you need to receive a donation from another site, please escalate your request to your ICB in the first instance. Your ICB will then escalate the request to Region (East of England), to approve and to carry out this action on your behalf. Where a request meets the above criteria, your ICB will submit the movement request to Region (for approval and action). How to submit a request Please include the following information with the request:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LOW THROUGHPUT SITESSites expected to administer fewer than 200 vaccinations during the programme have initially been allocated Sanofi Nuvaxovid vaccine, with their full allocation volume available from the outset. This approach reflects the limited wastage risk associated with this product and ensures these sites are not operationally constrained by phased release arrangements. Any additional vaccine supply beyond this allocation will be provided in Spikevax. This includes any provider requests for additional vaccine, and all TDM increases. This approach retains a national reserve of Nuvaxovid for deployment during the final weeks of the campaign, when demand is expected to be lower, reducing the risk of Spikevax wastage overall given its shorter 30-day refrigerated shelf life and multi dose vials. Detained Estates (DE) vaccination sites will continue to order and receive Nuvaxovid throughout the campaign. All other provider types, including hospital hubs, will receive Spikevax. Sites newly joining the programme will receive their initial allocations in Spikevax. If you have any questions, please contact your ICB |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PGD UPDATESNHS England Publishes Spring 2026 COVID‑19 Vaccination PGD 19 March 2026 — NHS England has officially authorised and released the Patient Group Direction (PGD) for use in the upcoming Spring 2026 COVID‑19 vaccination campaign. Download the Spring 2026 COVID‑19 Vaccination PGD This follows the earlier publication of operational guidance designed to support vaccination sites preparing to participate in this spring’s programme. Upcoming changes to vaccination legislation The legislation that enabled the development of National Protocols for COVID-19 vaccine administration is due to lapse on 31 March 2026. The Government has consulted on a replacement .the Vaccine Group Direction, a proposed new legal mechanism that would continue to allow suitably trained registered and non‑registered staff to administer vaccines. Subject to Parliamentary approval, the COVID‑19 Vaccine Group Direction for the spring programme is expected to be published on 1 April 2026. Service Timelines Vaccination period 13 April 2026 – 30 June 2026 Public bookings The national booking service and the 119 telephone line will be open for appointments from: 7 April 2026 – 29 June 2026 COVID‑19 Vaccination Service Registration Remains Open Pharmacy owners who wish to take part in the Spring 2026 vaccination campaign and have not yet registered can still do so by completing the electronic registration form: Access the COVID‑19 Vaccination Service registration declaration form Please note: pharmacies registering at this stage are not guaranteed vaccine supply at the start of the campaign. The registration form will remain available until 31 March 2026. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BANK HOLIDAY VACCINE DELIVERIESThere are no COVID-19 vaccine deliveries on these bank holidays:
Key dates for your orders
Action needed before ordering Before placing any order, check that your site has completed a stocktake on Site Stock Manager within the last 7 days. If you haven’t done a recent stocktake, the system will block your order. Once you submit a new stocktake, allow up to 2 hours for the system to update before trying to order again.
Support If you need support with stocktakes or ordering, contact your ICB. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
KEY RESOURCES & GUIDANCE
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HWE ICB TRAINING RECORDINGSRecordings of all training sessions are now available on the V&S Futures workspace, alongside updated training guides covering the key changes for spring. These include:
Recording Links:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FAQsHow do I know if I successfully signed up for the SS26 COVID campaign?
How do I know my allocation of vaccines?
How do I turn on or off the automated replenishment on the FDP platform?
When can I start uploading patient appointments to the MYA platform?
|


